Abstract:Neonatal sepsis is a major cause of morbidity and mortality. It is the third leading cause of neonatal mortality globally constituting 13% of overall neonatal mortality Despite the high burden of neonatal sepsis, high‐quality evidence in diagnosis and treatment is scarce. Possibly due to the diagnostic challenges of sepsis and the relative immunosuppression of the newborn, many neonates receive antibiotics for suspected sepsis. Antibiotics have become the most used therapeutics in neonatal intensive care units. The last Cochrane Review was updated in 2004. Given the clinical importance, an updated systematic review assessing the effects of different antibiotic regimens for early‐onset neonatal sepsis is needed. To assess the beneficial and harmful effects of different antibiotic regimens for early‐onset neonatal sepsis. We searched the following electronic databases: CENTRAL (2020, Issue 8); Ovid MEDLINE; Embase Ovid; CINAHL; LILACS; Science Citation Index EXPANDED and Conference Proceedings Citation Index – Science on 12 March 2021. We searched clinical trials databases and the reference lists of retrieved articles for randomised controlled trials (RCTs) and quasi‐RCTs. We included RCTs comparing different antibiotic regimens for early‐onset neonatal sepsis. We included participants from birth to 72 hours of life at randomisation. Three review authors independently assessed studies for inclusion, extracted data, and assessed risk of bias. We used the GRADE approach to assess the certainty of evidence. Our primary outcome was all‐cause mortality, and our secondary outcomes were: serious adverse events, respiratory support, circulatory support, nephrotoxicity, neurological developmental impairment, necrotising enterocolitis, and ototoxicity. Our primary time point of interest was at maximum follow‐up. We included five RCTs (865 participants). All trials were at high risk of bias. The certainty of the evidence according to GRADE was very low. The included trials assessed five different comparisons of antibiotics. We did not conduct any meta‐analyses due to lack of relevant data. Of the five included trials one trial compared ampicillin plus gentamicin with benzylpenicillin plus gentamicin; one trial compared piperacillin plus tazobactam with amikacin; one trial compared ticarcillin plus clavulanic acid with piperacillin plus gentamicin; one trial compared piperacillin with ampicillin plus amikacin; and one trial compared ceftazidime with benzylpenicillin plus gentamicin. None of the five comparisons found any evidence of a difference when assessing all‐cause mortality, serious adverse events, circulatory support, nephrotoxicity, neurological developmental impairment, or necrotising enterocolitis; however, none of the trials were near an information size that could contribute significantly to the evidence of the comparative benefits and risks of any particular antibiotic regimen. None of the trials assessed respiratory support or ototoxicity. The benefits and harms of different antibiotic regimens remain unclear due to the lack of well‐powered trials and the high risk of systematic errors. Current evidence is insufficient to support any antibiotic regimen being superior to another. Large RCTs assessing different antibiotic regimens in early‐onset neonatal sepsis with low risk of bias are warranted. Review question We reviewed available evidence on different antibiotic regimens for newborns (from birth to 72 hours of life), with early‐onset sepsis (as defined by trialists). Background Sepsis in newborns is a severe and potential lethal condition, caused by the body's response to an infection. Neonatal sepsis is the third leading cause of neonatal death globally Despite the high burden of sepsis in newborns, high‐quality evidence in diagnosis and treatment is scarce. This Cochrane Review was originally published in 2004. To identify the most appropriate antibiotic policies for neonatal sepsis, there is a need to base these policies on an updated well‐conducted review. Given the clinical importance, such a review assessing the effects of different antibiotic regimens for early‐onset neonatal sepsis is needed. Study characteristics The evidence is current to August 2020. We included five trials randomising 865 participants. The included trials compared five different antibiotic regimens. Key results We included five trials: one trial compared ampicillin plus gentamicin with benzylpenicillin plus gentamicin; one trial compared piperacillin plus tazobactam with amikacin; one trial compared ticarcillin plus clavulanic acid with piperacillin plus gentamicin; one trial compared piperacillin with ampicillin plus amikacin; and one trial compared ceftazidime with benzylpenicillin plus gentamicin. None of the five comparisons showed any difference when assessing death from all causes, serious adverse events (i.e. major complicat -Abstract Truncated-

Different antibiotic strategies in transient tachypnea of the newborn: an ambispective cohort study

Influence of different antibiotic strategies on outcomes of hospitalized neonates

Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

Effect of Improvement in Antibiotic Use Strategy on the Short-Term Clinical Outcome of Preterm Infants with a Gestational Age Of<35 Weeks

Early Antibiotic Use and Neonatal Outcomes Among Preterm Infants Without Infections

Evaluation of antibiotic stewardship among near-term and term infants admitted to a neonatal unit

Restrictive Use of Empirical Antibiotics is Associated with Improved Short Term Outcomes in Very Low Birth Weight Infants: A Single Center, Retrospective Cohort Study from China

Antibiotic Use in Neonatal Intensive Care Units in China: A Multicenter Cohort Study.

Antibiotic use among extremely low birth-weight infants from 2009 to 2021: a retrospective observational study

Comparative Study of Clinical Features, Treatment and Outcome of 1354 Cases of Transient Tachypnea of the Newborn in Different Gestational Age

Strategies to improve antibiotic use in the neonatal ICU

The OBTAINS Study: A Nationwide Cross-Sectional Survey on the Implementation of Extended or Continuous Infusion of Β-Lactams and Vancomycin among Neonatal Sepsis Patients in China

Influences of Initial Empiric Antibiotics with Ampicillin plus Cefotaxime on the Outcomes of Neonates with Respiratory Failure: A Propensity Score Matched Analysis

Neonatal ICU antibiotic use trends within an integrated delivery network

Efficacy of Budesonide, Epinephrine and Salbutamol Inhalation for Treatment of Transient Tachypnea of Newborn: Prospective Controlled Study

Comparison of Procalcitonin Guidance-Administered Antibiotics with Standard Guidelines on Antibiotic Therapy in Children with Lower Respiratory Tract Infections: A Retrospective Study in China.

Clinical Analysis of the Severity Related Factors of 602 Cases of Transient Tachypnea of the Newborn in Preterm Infants

A study on risk factors of intestinal bacteria colonization and antibiotic resistance in NICU neonates

Antimicrobial Stewardship in Neonates with Necrotizing Enterocolitis: A Quality Improvement Initiative

Antibiotic regimens for early-onset neonatal sepsis.

Trends in the antimicrobial susceptibility among Chinese neonates from 2012 to 2021: a multicenter study